Work

Abstract A076: VS-7375: An oral, selective KRAS G12D dual ON/OFF inhibitor with superior anti-tumor efficacy relative to ON-only KRAS inhibitors

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a076

Authors: Silvia Coma, Cristina Caffarra Malvezzi, Feng Yan, Fusheng Zhou, Yu Wang, Nathan Sanburn, Chiara Ambrogio, Jonathan A. Pachter

Institutions: Verastem (United States), University of Turin, Genfleet Therapeutics (Shanghai) Inc. (China)

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444341

Cites:

Cited by: 1

Related to: